Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Multitargeted antibacterial mechanisms of Iturin A derived from Bacillus amyloliquefaciens against tomato bacterial wilt.

Created on 04 Nov 2026

Authors

Jinyu Yang, Tianbo Liu, Zhanjie Li, Tiansheng Zhu, Luping Chi, Xu Yan, Baoxiang Pan, Jinchang Liang, Xiaoqiang Wang

Published in

Frontiers in microbiology. Volume 17. Pages 1944894. Epub Oct 20, 2026.

Abstract

Tomato bacterial wilt is a devastating disease caused by Ralstonia solanacearum. This study aimed to evaluate the antibacterial activity of Iturin A, a cyclic lipopeptide produced by Bacillus amyloliquefaciens strain Cas02, against R. solanacearum and investigate its mechanisms of action. The results indicated that Iturin A effectively inhibited the growth of R. solanacearum with an MIC and IC50 of 25.00 and 15.79 μg/mL, respectively. In pot experiments, Iturin A significantly reduced disease incidence with a control efficacy of 74.27%. Microscopy observations revealed that Iturin A induced severe morphological damage, including membrane disruption and cytoplasmic leakage, and inhibited biofilm formation. Additionally, Iturin A caused the accumulation of intracellular reactive oxygen species, a decrease in succinate dehydrogenase activity, reductions in NAD+ and NADH content, and alterations in cytochrome c oxidase staining, indicating disruption of the electron transport chain and energy metabolism. Transcriptome analysis further indicated the downregulation of genes related to the membrane structure and type III secretion system. Overall, these findings suggest that Iturin A may exert antibacterial effects through multiple pathways, including impairment on cell integrity, biofilm formation, energy metabolism, and virulence-associated functions. This study provides a basis for further exploration of Iturin A as a potential antibacterial agent for managing tomato bacterial wilt.

PMID:
42978972
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement